Literature DB >> 32389216

Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy.

Kathryn A Phillips1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32389216      PMCID： PMC7217974          DOI： 10.1016/j.jval.2020.03.002

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  7 in total

Review 1.  Precision Medicine: From Science To Value.

Authors:  Geoffrey S Ginsburg; Kathryn A Phillips
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

2.  Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Authors:  Kathryn A Phillips; Patricia A Deverka; Gillian W Hooker; Michael P Douglas
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

3.  Assessing the Value and Implications of Personalized/Precision Medicine and the "Lessons Learned" for Emerging Technologies: An Introduction.

Authors:  Kathryn A Phillips
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

4.  Assessing the Value of Next-Generation Sequencing Technologies: An Introduction.

Authors:  Kathryn A Phillips
Journal:  Value Health       Date:  2018-08-23       Impact factor: 5.725

5.  Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.

Authors:  Eric Faulkner; Anke-Peggy Holtorf; Surrey Walton; Christine Y Liu; Hwee Lin; Eman Biltaj; Diana Brixner; Charles Barr; Jennifer Oberg; Gurmit Shandhu; Uwe Siebert; Susan R Snyder; Simran Tiwana; John Watkins; Maarten J IJzerman; Katherine Payne
Journal:  Value Health       Date:  2020-04-01       Impact factor: 5.725

Review 6.  Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.

Authors:  Patricia A Deverka; Michael P Douglas; Kathryn A Phillips
Journal:  Value Health       Date:  2020-03-26       Impact factor: 5.725

7.  Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.

Authors:  Julia R Trosman; Michael P Douglas; Su-Ying Liang; Christine B Weldon; Allison W Kurian; Robin K Kelley; Kathryn A Phillips
Journal:  Value Health       Date:  2020-03-19       Impact factor: 5.725
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.